Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026GlobeNewsWire • 03/18/26
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in DermatologyGlobeNewsWire • 12/10/25
Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/13/25
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/12/25
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 11/12/25
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025GlobeNewsWire • 11/05/25
Journey Medical Corporation Reports Combined Emrosi™ (DFD-29) Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology ConferenceGlobeNewsWire • 10/24/25
Journey Medical Corporation to Participate in October 2025 Investor ConferencesGlobeNewsWire • 10/08/25
Journey Medical Corporation to Participate in September 2025 Investor ConferencesGlobeNewsWire • 09/03/25
CoreWeave, CAVA Group, Journey Medical And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionBenzinga • 08/13/25
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue EstimatesZacks Investment Research • 08/12/25
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 08/12/25
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11GlobeNewsWire • 08/07/25
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025GlobeNewsWire • 08/05/25
Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 ReleaseZacks Investment Research • 08/04/25
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology ConferenceGlobeNewsWire • 06/20/25
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TVGlobeNewsWire • 06/09/25